There have been 50 recent insider transactions recorded for Deciphera Pharmaceuticals, Inc. (DCPH), including 27 buys and 22 sells. Total insider buying was valued at $12.24M and total insider selling at $1.51M.
Notable insiders with recent activity include Brightstar Associates Llc, Sherman Matthew L, Kelly Thomas Patrick. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — DCPH
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-04-22 |
Brightstar Associates Llc |
10 Percent Owner |
Option Exercise (ITM) |
48,136 |
$0.01 |
$481.36 |
- |
| 2024-02-16 |
Sherman Matthew L |
EVP & Chief Medical Officer |
Informative Sell |
2,615 |
$15.62 |
$40.84K |
108,739 |
| 2024-02-16 |
Kelly Thomas Patrick |
Chief Financial Officer |
Informative Sell |
3,010 |
$15.62 |
$47.01K |
80,350 |
| 2024-02-16 |
Martin Daniel C. |
Chief Commercial Officer |
Informative Sell |
2,267 |
$15.62 |
$35.41K |
55,118 |
| 2024-02-16 |
Pitman Jama |
SVP, Chief Development Officer |
Informative Sell |
2,267 |
$15.62 |
$35.41K |
68,031 |
| 2024-02-15 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU Award |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU Award |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Hoerter Steven L. |
President and CEO |
RSU Award |
298,100 |
$15.92 |
$4.75M |
298,100 |
| 2024-02-15 |
Martin Daniel C. |
Chief Commercial Officer |
RSU Award |
38,900 |
$15.92 |
$619.29K |
38,900 |
| 2024-02-15 |
Dhanak Dashyant |
EVP & Chief Scientific Officer |
RSU Award |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Pitman Jama |
SVP, Chief Development Officer |
RSU Award |
38,900 |
$15.92 |
$619.29K |
38,900 |
| 2024-02-07 |
Brightstar Associates Llc |
10 Percent Owner |
Option Exercise (ITM) |
914,001 |
$0.01 |
$9.14K |
48,136 |
| 2024-01-16 |
Sherman Matthew L |
EVP & Chief Medical Officer |
Informative Sell |
2,435 |
$14.47 |
$35.23K |
94,079 |
| 2024-01-16 |
Allen Patricia L |
Director |
RSU Award |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Kelly Thomas Patrick |
Chief Financial Officer |
Informative Sell |
2,435 |
$14.47 |
$35.23K |
66,085 |
| 2024-01-16 |
Squarer Ron |
Director |
RSU Award |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Walsh Dennis Leo |
Director |
RSU Award |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Martin Daniel C. |
Chief Commercial Officer |
Informative Sell |
1,624 |
$14.47 |
$23.5K |
47,660 |
| 2024-01-16 |
Friedman Franklin Stuart |
Director |
RSU Award |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Pitman Jama |
SVP, Chief Development Officer |
Informative Sell |
1,624 |
$14.47 |
$23.5K |
50,573 |
| 2023-12-13 |
Sherman Matthew L |
EVP & Chief Medical Officer |
Informative Sell |
2,792 |
$15.37 |
$42.9K |
96,514 |
| 2023-12-13 |
Kelly Thomas Patrick |
Chief Financial Officer |
Informative Sell |
2,792 |
$15.37 |
$42.9K |
68,520 |
| 2023-12-13 |
Hoerter Steven L. |
President and CEO |
Informative Sell |
30,664 |
$15.37 |
$471.22K |
72,763 |
| 2023-12-13 |
Martin Daniel C. |
Chief Commercial Officer |
Informative Sell |
1,727 |
$15.37 |
$26.54K |
49,284 |
| 2023-12-13 |
Pitman Jama |
See Remarks |
Informative Sell |
1,662 |
$15.37 |
$25.54K |
52,197 |
| 2023-12-12 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU Award |
8,244 |
- |
- |
99,306 |
| 2023-12-12 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU Award |
8,244 |
- |
- |
71,312 |
| 2023-12-12 |
Hoerter Steven L. |
President and CEO |
RSU Award |
62,500 |
- |
- |
103,427 |
| 2023-12-12 |
Martin Daniel C. |
Chief Commercial Officer |
RSU Award |
5,576 |
- |
- |
51,011 |
| 2023-12-12 |
Pitman Jama |
See Remarks |
RSU Award |
5,576 |
- |
- |
53,859 |
| 2023-11-30 |
Martin Daniel C. |
Chief Commercial Officer |
Informative Sell |
17,801 |
$12.57 |
$223.76K |
45,435 |
| 2023-10-30 |
Sherman Matthew L |
EVP & Chief Medical Officer |
Informative Sell |
2,360 |
$12.02 |
$28.36K |
90,628 |
| 2023-10-30 |
Kelly Thomas Patrick |
Chief Financial Officer |
Informative Sell |
2,316 |
$12.02 |
$27.83K |
63,068 |
| 2023-10-30 |
Hoerter Steven L. |
President and CEO |
Informative Sell |
21,573 |
$12.02 |
$259.26K |
40,927 |
| 2023-10-30 |
Martin Daniel C. |
Chief Commercial Officer |
Informative Sell |
1,407 |
$12.02 |
$16.91K |
62,884 |
| 2023-10-30 |
Pitman Jama |
See Remarks |
Informative Sell |
1,407 |
$12.02 |
$16.91K |
48,283 |
| 2023-10-28 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU Award |
8,244 |
- |
- |
92,988 |
| 2023-10-28 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU Award |
8,244 |
- |
- |
65,384 |
| 2023-10-28 |
Hoerter Steven L. |
President and CEO |
RSU Award |
62,500 |
- |
- |
62,500 |
| 2023-10-28 |
Martin Daniel C. |
Chief Commercial Officer |
RSU Award |
5,576 |
- |
- |
64,291 |
| 2023-10-28 |
Pitman Jama |
See Remarks |
RSU Award |
5,576 |
- |
- |
49,690 |
| 2023-10-02 |
Sherman Matthew L |
EVP & Chief Medical Officer |
Informative Sell |
2,942 |
$12.68 |
$37.3K |
84,744 |
| 2023-09-15 |
Dhanak Dashyant |
EVP & Chief Scientific Officer |
RSU Award |
65,900 |
- |
- |
65,900 |
| 2023-09-05 |
Dhanak Dashyant |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-06-21 |
Allen Patricia L |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Squarer Ron |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Kelley Susan L. |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Benz Edward J. Jr |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Walsh Dennis Leo |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Martin John Richard |
Director |
RSU Award |
30,000 |
$14.91 |
$447.3K |
30,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
